Malaysia

AstraZeneca Covid-19 vaccine safe for M’sian use: Adham

Safety data shows no serious side effects reported, says health minister

Updated 5 years ago · Published on 24 Mar 2021 6:45PM

AstraZeneca Covid-19 vaccine safe for M’sian use: Adham
Health Minister Datuk Seri Dr Adham Baba says the ministry is committed to carrying out continuous monitoring to ensure the quality, safety, and effectiveness of the Covid-19 vaccines are always guaranteed. – AFP pic, March 24, 2021

PUTRAJAYA – The AstraZeneca Covid-19 vaccine is safe for use in Malaysia, said Health Minister Datuk Seri Dr Adham Baba.

He said the AstraZeneca Covid-19 vaccine safety data – obtained from clinical studies as of November 4 last year involving 12,000 volunteers – showed that no serious side effects were reported.

The usual side effects frequently reported were soreness at the site of inoculation, lethargy, headaches, and others classified as mild or moderate onsets.

“Data also showed that post-vaccination effects were significantly reduced after the second dose was administered,” he said in a statement regarding the safety status of the AstraZeneca Covid-19 vaccine, which was approved for registration by the Drug Control Authority on March 2.

According to him the clinical studies also concluded that there were no safety issues concerning its effects on the blood’s profile and contents, including blood clotting, after receiving the vaccine jab.

Dr Adham said AstraZeneca Sdn Bhd had also held a meeting with the National Pharmaceutical Regulatory Division on March 17 to explain the actual situation regarding the safety issue of the AstraZeneca Covid-19 vaccine, especially relating to blood clots (thromboembolic events).

According to the company, a total of 17 million people had received the AstraZeneca Covid-19 vaccine in the European Union and the United Kingdom as of March 8, with 15 cases of deep vein thrombosis and 22 cases of pulmonary embolism reported from among the recipients.

Dr Adham said the company had conducted detailed studies of all the cases and concluded that there was no solid evidence that could link the vaccine to the risk of thromboembolic events.

“The total number of thromboembolic event cases reported was also far lower compared to the average expected cases in that population size and the conclusion was also supported by the European Medicines Agency.

“Therefore, it is concluded that the AstraZeneca Covid-19 vaccine is safe for use,” he said.

Dr Adham said the Health Ministry was committed to carrying out continuous monitoring to ensure the quality, safety, and effectiveness of the Covid-19 vaccines are always guaranteed.

Recipients can report adverse effects following Covid-19 vaccine jabs through health personnel, directly to the National Pharmaceutical Regulatory Agency (NPRA) website (www.npra.gov.my) or through the MySejahtera application for mild adverse effects, he said.

On March 15, National Covid-19 Immunisation Programme Coordinating Minister Khairy Jamaluddin said Malaysia would proceed with the purchase and acquisition of AstraZeneca Covid-19 vaccines as there has been no evidence that the vaccine causes blood clots.

The Science, Technology, and Innovation Minister said AstraZeneca had informed Malaysia on the side effects of the vaccine and so far, there has been no data to indicate any direct link between the vaccine and reports of blood clots in people, which had resulted in deaths in a few countries.

Several countries such as Denmark, Norway, Iceland, and Thailand have reportedly paused the rollout of AstraZeneca’s vaccine following reports of blood clots occurring in several individuals after being vaccinated. – Bernama, March 24, 2021

Related News

Malaysia / 1mth

Dr Noor Hisham denies claims that the Pfizer vaccine caused deaths

Malaysia / 5mth

Covid-19 cases in Malaysia stable, no deaths recorded this year – MOH

Malaysia / 8mth

Bad move to channel EPF dividends into Account 3 for festive withdrawals, cautions economist

Opinion / 1y

A tale of two administrations: How Warisan and GRS shaped Sabah’s future

Malaysia / 1y

Sabah woman unvaccinated during Covid-19 sues authorities for loss of income, emotional distress

Malaysia / 1y

MOH closely monitoring Covid-19 amid rising cases in neighbouring countries

Spotlight

Malaysia

MB’s resignation: “I was not informed” – Jalaluddin

Malaysia

Ismail’s resignation raises various questions: Work of hidden hands?

Malaysia

Padang Rengas dispute exposes challenge facing possible BN-PN pact

Malaysia

Khalid urges Anwar to reject Anthony Loke’s resignation amid political uncertainty

By Alfian Z.M. Tahir

Malaysia

Zahid: One name submitted for new Negeri MB

Malaysia

Viral abuse video leads to murder charge against couple in father's death

You may be interested

Malaysia

Data centre economic returns, Sabah-Sarawak parliamentary seats to dominate Dewan Rakyat

Malaysia

Five Malaysians arrested as Thailand busts RM28.9 million drug smuggling network

Malaysia

Mukhriz loses bid to block LHDN’s RM5m tax claim, must pursue statutory appeal

Malaysia

Data centre boom exposes Malaysia to wider cybersecurity threats, NACSA warns

Malaysia

Malaysia faces 27-year window to prepare for aged-nation transition

Malaysia

Migrants offered RM5,000 'pay-after-employment' deal to enter Malaysia illegally

Malaysia

Two of five Malaysians held in Thailand over 240kg meth haul have prior drug convictions

Malaysia

Sabah, Sarawak's local representation in civil service faces Dewan Rakyat scrutiny